Alternatives to Johnson & Johnson

Global healthcare technology leader developing innovative solutions for challenging health problems.

Global pharmaceutical company focused on eye health, gastroenterology, and dermatology.

A multinational consumer goods corporation.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered spatial biology platform for precision medicine and drug development.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

AI-powered breast cancer detection and risk assessment solutions.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Pioneering vision restoration therapies for severe retinal degenerations.